Specimen Banking From Patients With Lung Cancer
18 Years
85 Years
Both
Lung Neoplasms
Trial Information
Specimen Banking From Patients With Lung Cancer
The aims of the study are as follows: 1) to continue to unravel the complex biology of lung
cancer 2) to identify early detection and prognostic markers to guide therapeutic decision
3) to define markers of response and/or resistance to drug therapy, and 4) to identify new
therapeutic and prevention targets.
Inclusion Criteria:
1. Subjects who are undergoing further testing for the diagnosis or treatment of lung
cancer.
2. Oral and written informed consent
Exclusion Criteria:
1. Any individual who does not give oral and written consent for participation
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translational research.
Outcome Description:
No statistical analysis will be applied to the overall collection of samples. Rather, each project that utilized tissue bank resources will require an appropriate statistical plan to be submitted along with the initial tissue request.
Outcome Time Frame:
6 years
Safety Issue:
No
Principal Investigator
Wilbur Franklin, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Colorado, Denver
Authority:
United States: Institutional Review Board
Study ID:
04-0688
NCT ID:
NCT01585675
Start Date:
November 2005
Completion Date:
May 2020
Related Keywords:
- Lung Neoplasms
- Lung Cancer
- Neoplasms
- Lung Neoplasms
Name | Location |
|---|---|
| University of Colorado Cancer Center | Denver, Colorado 80262 |
